• 1
    Egawa S, Suyama K, Ohori M et al. Early detection of prostate cancer. Cancer 1995; 76: 46372.
  • 2
    Oesterling JE, Kumamoto Y, Tsukamoto T et al. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br. J. Urol. 1995; 75: 34753.
  • 3
    Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45: 212.
  • 4
    Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus detected ultrasound guided transrectal core biopsies of the prostate. J. Urol. 1989; 142: 715.
  • 5
    D’Amico AV, Whittington R, Malkowicz SB et al. Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J. Clin. Oncol. 2000; 18: 116472.
  • 6
    Gohji K, Okamoto M, Takenaka A, Nomi M, Fujii A. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men. BJU Int. 1999; 83: 3942.
    Direct Link:
  • 7
    Gilliland FD, Hoffman RM, Hamilton A et al. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J. Urol. 1999; 162: 13415.
  • 8
    Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71: 9338.
  • 9
    Epstein JI, Chan DW, Sokoll LJ et al. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J. Urol. 1998; 160: 240711.
  • 10
    Ravery V, Szabo J, Toublanc M et al. A single positive prostate biopsy in six does not predict a low-volume prostate tumor. Br. J. Urol. 1996; 77: 7248.
  • 11
    Wang X, Brannigan RE, Rademaker AW, McVary KT, Oyasu R. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen. J. Urol. 1997; 158: 14315.
  • 12
    D’Amico AV, Wu Y, Chen MH, Nash M, Renshaw AA, Richie JP. Pathological findings and prostate specific antigen outcome after radical prostatectomy for patients diagnosed on the basis of a single microscopic focus of prostate carcinoma with a Gleason score = 7. Cancer 2000; 89: 18107.
  • 13
    Egawa S, Koh H, Satoh T et al. Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage in Japanese prostate cancer. Jpn J. Clin. Oncol. 1996; 26: 43844.
  • 14
    Egawa S, Suyama K, Ohori M et al. Early detection of prostate cancer. Results of a prostate specific antigen based detection program in Japan. Cancer 1995; 76: 46372.
  • 15
    International Union Against Cancer. In: Sobin LH, Wittekind CH (eds). TNM Classification of Malignant Tumors, 5th edn. John Wiley & Sons, New York, 1997; 1703.
  • 16
    Ro YJ, Grignon DJ, Amin MB. Atlas of Surgical Pathology of the Male Reproductive Tract. W.B. Saunders, Philadelphia, 1997.